Stock Code: 688133 stock abbreviation: Shanghai Titan Scientific Co.Ltd(688133) Shanghai Titan Scientific Co.Ltd(688133)
Room 1110, building 1, No. 100, Qinzhou Road, Xuhui District, Shanghai
Issue A-Shares to specific objects in 2021
Prospectus
(Registration draft)
Sponsor (lead underwriter)
North block of excellence Times Square (phase II), No. 8, Zhongxin Third Road, Futian District, Shenzhen, Guangdong Province
January 2002
Statement
The company and all directors, supervisors and senior managers promise that there are no false records, misleading statements or major omissions in the prospectus and other information disclosure materials, and shall be jointly and severally liable for their authenticity, accuracy and completeness.
The person in charge of the company, the person in charge of accounting and the person in charge of accounting institutions shall ensure that the financial and accounting data in the prospectus are true and complete.
Any decision or opinion made by China Securities Regulatory Commission and Shanghai Stock Exchange on this issuance does not indicate that they guarantee the authenticity, accuracy and integrity of the application documents and the information disclosed, nor do they indicate that they make substantive judgment or guarantee on the profitability, investment value of the issuer or the income of investors. Any statement to the contrary is a false statement.
According to the provisions of the securities law, the issuer shall be responsible for the changes in the operation and income of the issuer after the securities are issued according to law. Investors independently judge the investment value of the issuer, make investment decisions independently, and bear the investment risks caused by changes in the operation and income of the issuer or changes in securities prices after securities are issued according to law.
catalogue
Declare that 1 catalog 2 interpretation 4 I. Basic terms 4 II. Professional terms Chapter I basic information of the issuer 6 I. ownership structure, controlling shareholders and actual controllers 6 II. Main characteristics of the industry and industry competition 7 III. main business model, main contents of products or services IV. scientific and technological innovation level and mechanisms or measures to maintain scientific and technological innovation ability V. existing business development arrangements and future development strategies Chapter II summary of this securities offering 27 I. background and purpose of this offering 27 II. Issuing object and relationship with the issuer 3. The price or pricing method of the securities issued, the number of securities issued, and the sales restriction period 31 IV. the raised funds are invested in 32 v. whether this issuance constitutes a connected transaction 33 VI. will this issuance lead to changes in the company’s control VII. The approval of the issuance plan by relevant competent authorities and the procedures to be submitted for approval Chapter III feasibility analysis of the use of the raised funds 35 I. Basic information of the project invested by the raised funds 35 II. Description of the main business of the raised funds invested in the field of scientific and technological innovation, and the way in which the implementation of the raised investment project promotes the improvement of the company’s scientific and technological innovation level 52 III. The investment project with raised funds involves the progress of approval, approval or filing matters related to project initiation, land and environmental protection, the procedures to be performed and whether there are major uncertainties Chapter IV discussion and analysis of the board of directors on the impact of this issuance on the company 57 I. after the completion of this offering, the change or integration plan of the business and assets of the listed company 57 II. Changes in the scientific research and innovation ability of listed companies after the completion of this offering fifty-seven
3、 Changes in the control structure of listed companies after the completion of this offering 58 IV. after the completion of this offering, there is horizontal competition or potential horizontal competition between the listed company and the issuing object, the controlling shareholder and actual controller of the issuing object 58 v. possible related party transactions between the listed company and the issuing object and the controlling shareholders and actual controllers of the issuing object after the completion of this offering 58 Chapter V risk factors related to this offering 59 I. factors that may have a significant adverse impact on the company’s core competitiveness, business stability and future development
…… 59 II. Factors that may lead to the failure of this offering or insufficient funds raised 63 III. factors that may have a significant adverse impact on the implementation process or implementation effect of the raised investment project 64 Chapter VI statements related to this offering 69 I. statement of all directors, supervisors and senior managers 69 II. Statement of controlling shareholder and actual controller 72 III. statement of the sponsor and its sponsor representative 73 IV. statement of the chairman and general manager of the recommendation institution 74 v. statement of the issuer’s lawyer 75 VI. statement of the audit institution 76 VII. Statement of the board of directors of the issuer seventy-seven
interpretation
In this report, unless the context otherwise requires, the following words or abbreviations have the following meanings: I. The basic terms company, Shanghai Titan Scientific Co.Ltd(688133) and issuer refer to Shanghai Titan Scientific Co.Ltd(688133)
Shanghai Ruihe refers to Shanghai Ruihe Xinxin venture capital center (limited partnership)
Citic Securities Company Limited(600030) means Citic Securities Company Limited(600030)
Thermo Fisher refers to Thermo Fisher Scientific
Merck KGaA means Merck KGaA
Danaher means Danaher Corporation
Sinopharm reagent refers to Sinopharm Chemical Reagent Co., Ltd
Shanghai Aladdin Biochemical Technology Co.Ltd(688179) means Shanghai Aladdin Biochemical Technology Co.Ltd(688179)
Xilong Scientific Co.Ltd(002584) means Xilong Scientific Co.Ltd(002584)
Anpu experiment refers to Shanghai Anpu Experimental Technology Co., Ltd
Heyuan private equity refers to Shanghai Titan Heyuan Private Equity Fund Management Co., Ltd
Heyuan phase I fund refers to Shanghai Titan Heyuan phase I private investment fund partnership (limited partnership)
Taiyuanchuang refers to Shanghai taiyuanchuang Management Consulting Co., Ltd
CSRC refers to the China Securities Regulatory Commission
The articles of association and the articles of association refer to Shanghai Titan Scientific Co.Ltd(688133) articles of association. The sponsor (lead underwriter) refers to the lawyer of Citic Securities Company Limited(600030) issuer, Deheng Law Firm refers to the accountant of Beijing Deheng Law Firm, and Daxin accounting firm refers to Daxin accounting firm (special general partnership)
Company law means the company law of the people’s Republic of China
Securities Law means the securities law of the people’s Republic of China
The reporting period refers to 2018, 2019, 2020 and January September 2021
This issuance refers to the issuer’s issuance of RMB common shares (A shares) to specific objects in accordance with the conditions set out in this prospectus
A share refers to the RMB ordinary shares with a par value of 1.00 yuan per share issued this time
Yuan and 10000 yuan refer to RMB yuan and 10000 yuan
2、 Technical terms
Reagent, also known as biochemical reagent or test drug, is a pure chemical used to realize chemical reaction, analysis and test, research and test, teaching experiment and chemical formula
Precursors, raw materials, chemical additives and other substances that can be used in the manufacture of drugs under the control of the state.
Item precursor chemicals refer to 24 varieties in three categories listed in China. The first category is mainly used as raw materials for drug manufacturing, and the second and third categories are auxiliary preparations that can be used for drug manufacturing
The abbreviation of enterprise resource planning refers to a management platform that provides decision-making and operation means for enterprise decision-makers and employees with systematic management ideas based on information technology of information ERP system
Stock keeping unit refers to the basic unit of inventory in / out measurement. SKU refers to the unit of pieces, boxes, pallets, etc. Now it has been extended to the abbreviation of unified product number, and each product corresponds to a unique SKU number
TOC refers to total organic carbon, or TOC for short, that is, total organic carbon analyzer, which represents the comprehensive index of total organic matter in water with carbon content
The abbreviation of original equipment manufacturer, also known as fixed-point production, commonly known as OEM (production), basically means that brand producers do not directly produce products, but use their own key core technologies to design and develop new products and control sales channels, The specific processing tasks are entrusted to other manufacturers of similar products through contract ordering
Titration is not only a chemical experimental operation, but also a means of quantitative analysis. It determines the content of a solute by the quantitative reaction of two solutions
The mirror image cannot coincide with the original object, just as the left hand and the right hand are mirror images of each other and cannot overlap. This kind of chiral refers to that the object is a chiral object, and the separation and detection of isomers of chiral drugs is chiral analysis
Identify groups according to chemical shifts; The number of coupling splitting peaks and coupling constant determine the nuclear magnetic finger of group coupling; The proton ratio of each group is determined according to the integral area of each h peak to achieve the qualitative and quantitative detection of the compound
Radio frequency identification (RFID) technology, also known as radio frequency identification, is a communication technology. It can identify specific targets and read and write relevant data through radio signals without establishing mechanical or optical contact between the identification system and specific targets
Note: the mantissa difference or inconsistency of the data involved in this prospectus is caused by rounding.
Chapter I basic information of the issuer
1、 Ownership structure, controlling shareholders and actual controllers
(I) basic information of the company
Chinese name Shanghai Titan Scientific Co.Ltd(688133)
English Name: Shanghai Titan scientific Co., Ltd
Registered capital: 76248960 yuan
Registered address: room 1110, building 1, No. 100, Qinzhou Road, Xuhui District, Shanghai
Listing place: Shanghai Stock Exchange
Stock abbreviation Shanghai Titan Scientific Co.Ltd(688133)
Stock Code: 688133 SH
Legal representative: Zhang Qing
Gao Xiang, Secretary of the board of directors
Tel: 021-51701699
Operation of non pharmaceutical precursor chemicals (see the Filing Certificate for details), operation of hazardous chemicals (wholesale rental of storage facilities) (see the copy for the scope of license). (for projects subject to approval according to law, business activities can be carried out only after being approved by relevant departments, and the specific business projects shall be subject to the approval documents or licenses of relevant departments) general projects: engaged in technology development, technology transfer and Technical consultation and technical service
